Nath Bio-Genes (India) Ltd (NATHBIOGEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 628630, "name": "Nath Bio-Genes", "stock_name": "Nath Bio-Genes", "full_name": "Nath Bio-Genes (India) Ltd", "name_url": "stocks-analysis/nath-bio-genes", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "149.70", "chg": 0.5, "chgp": "0.34%", "dir": 1, "prev_price": "149.20", "mcapval": "284.00 Cr", "mcap": "Micro Cap", "scripcode": 537291, "symbol": "NATHBIOGEN", "ind_name": "Other Agricultural Products", "ind_code": 107, "indexname": "India SENSEX", "isin": "INE448G01010", "curr_date": "Apr 09", "curr_time": "", "bse_nse_vol": "15.04 k", "exc_status": "Active", "traded_date": "Apr 09, 2026", "traded_date_str": "2026 04 09", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nath-bio-genes-628630-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Nath Bio-Genes (India) Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-upgraded-to-sell-on-technical-improvement-despite-weak-fundamentals-3936587", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3936587.png", "date": "2026-04-08 08:17:53", "description": "Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The micro-cap agricultural products company’s recent performance and valuation metrics have prompted a reassessment across quality, valuation, financial trend, and technical parameters, signalling cautious optimism for investors." }, { "title": "Nath Bio-Genes (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-strong-sell-3932876", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3932876.png", "date": "2026-04-04 10:10:35", "description": "Nath Bio-Genes (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Nath Bio-Genes Falls to 52-Week Low of Rs 127 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-india-ltd-falls-to-52-week-low-amidst-continued-downtrend-3925124", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NathBioGenesInd_priceRelatedfactors_3925124.png", "date": "2026-03-30 13:49:01", "description": "For the second consecutive session, Nath Bio-Genes (India) Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 127 on 30 Mar 2026, marking a 5.85% decline over two days amid broader market weakness." }, { "title": "Nath Bio-Genes Falls 7.43%: 3 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-falls-743-3-key-factors-driving-the-weekly-decline-3921993", "imagepath": "", "date": "2026-03-28 15:02:17", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Mar:</strong> Stock hits 52-week low at Rs.135 amid broad market weakness</p>\n <p><strong>24 Mar:</strong> Downgrade to Strong Sell by MarketsMOJO due to worsening fundamentals and technicals</p>\n <p><strong>27 Mar:</strong> New 52-week low at Rs.129.15 as downtrend continues</p>\n <p><strong>27 Mar Close:</strong> Week ends at Rs.129.65, down 7.43%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.140.05</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div..." }, { "title": "Nath Bio-Genes Falls to 52-Week Low of Rs 129.15 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-india-ltd-falls-to-52-week-low-amid-continued-downtrend-3919288", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NathBioGenesInd_priceRelatedfactors_3919288.png", "date": "2026-03-27 11:22:16", "description": "A sharp decline in Nath Bio-Genes (India) Ltd has pushed the stock to a fresh 52-week low of Rs 129.15 on 27 Mar 2026, marking a significant 5% intraday drop and extending the recent downtrend despite a brief two-day rally." }, { "title": "Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3909402", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NathBioGenesInd_mojoScore_3909402.png", "date": "2026-03-24 08:31:18", "description": "Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has been downgraded from a Sell to a Strong Sell rating as of 23 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, weak long-term fundamentals, and a cautious valuation outlook, signalling heightened risks for investors amid ongoing market pressures." }, { "title": "Nath Bio-Genes Falls to 52-Week Low of Rs 135 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-india-ltd-stock-hits-52-week-low-at-rs135-3907992", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NathBioGenesInd_priceRelatedfactors_3907992.png", "date": "2026-03-23 13:13:53", "description": "A sharp decline of 3.61% today dragged Nath Bio-Genes (India) Ltd to a fresh 52-week low of Rs 135, extending a downward trajectory that has seen the stock underperform the broader market significantly over the past year." }, { "title": "Nath Bio-Genes (India) Ltd Upgraded to Sell Amid Mixed Technicals and Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-upgraded-to-sell-amid-mixed-technicals-and-weak-fundamentals-3895910", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NathBioGenesInd_mojoScore_3895910.png", "date": "2026-03-17 08:27:14", "description": "Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The company’s micro-cap status, flat recent financial performance, and subdued institutional interest continue to weigh on sentiment, while modest improvements in technical indicators have prompted a cautious reassessment of its market stance." }, { "title": "Nath Bio-Genes (India) Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-strong-sell-3893143", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NathBioGenesInd_mojoScore_3893143.png", "date": "2026-03-16 10:10:47", "description": "Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 16 March 2026, providing an up-to-date view of the company’s position in the market." } ], "total": 157, "sid": "628630", "stock_news_url": "https://www.marketsmojo.com/news/nath-bio-genes-india-628630" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "26-Mar-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "31-Jan-2026", "details": "Investor Presentation of Financial Results as on 31st December 2025", "source": "BSE" }, { "caption": "Outcome Of Board Meeting", "datetime": "31-Jan-2026", "details": "Financial Results as on 31st December 2025.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Mar: Stock hits 52-week low at Rs.135 amid broad market weakness

24 Mar: Downgrade to Strong Sell by MarketsMOJO due to worsening fundamentals and technicals

27 Mar: New 52-week low at Rs.129.15 as downtrend continues

27 Mar Close: Week ends at Rs.129.65, down 7.43%

Week Open

Rs.140.05

Week CloseRead full news article

Nath Bio-Genes Falls to 52-Week Low of Rs 129.15 as Sell-Off Deepens

2026-03-27 11:22:16

A sharp decline in Nath Bio-Genes (India) Ltd has pushed the stock to a fresh 52-week low of Rs 129.15 on 27 Mar 2026, marking a significant 5% intraday drop and extending the recent downtrend despite a brief two-day rally.

Read full news article

Nath Bio-Genes Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-03-24 08:31:18

Nath Bio-Genes (India) Ltd, a micro-cap player in the Other Agricultural Products sector, has been downgraded from a Sell to a Strong Sell rating as of 23 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, weak long-term fundamentals, and a cautious valuation outlook, signalling heightened risks for investors amid ongoing market pressures.

Read full news article

Nath Bio-Genes Falls to 52-Week Low of Rs 135 as Sell-Off Deepens

2026-03-23 13:13:53

A sharp decline of 3.61% today dragged Nath Bio-Genes (India) Ltd to a fresh 52-week low of Rs 135, extending a downward trajectory that has seen the stock underperform the broader market significantly over the past year.

Read full news article

Nath Bio-Genes (India) Ltd Upgraded to Sell Amid Mixed Technicals and Weak Fundamentals

2026-03-17 08:27:14

Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The company’s micro-cap status, flat recent financial performance, and subdued institutional interest continue to weigh on sentiment, while modest improvements in technical indicators have prompted a cautious reassessment of its market stance.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Strong Sell

2026-03-16 10:10:47

Nath Bio-Genes (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 March 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 16 March 2026, providing an up-to-date view of the company’s position in the market.

Read full news article